Lekanidi et al. evaluated 60 breast cancer patients with BMs and showed that ER-negative HER2-positive patients were more likely to present with a larger number of lesions, more brain stem or occipital metastases, and hydrocephalus [5]. Here, ERBB2 is linked to breast carcinoma.